首页> 外国专利> The process of preparau00c7u00e7o of formulations of semicarbazonas and / or tiossemicarbazonas with cyclodextrins and their derivatives and products obtained from this process

The process of preparau00c7u00e7o of formulations of semicarbazonas and / or tiossemicarbazonas with cyclodextrins and their derivatives and products obtained from this process

机译:用环糊精及其衍生物和产物制得的半卡巴那霉素和/或硫代半卡巴那唑制剂的制备方法

摘要

The process of preparau00c7u00e7o of formulations of semicarbazonas and / or tiossemicarbazonas with cyclodextrins and their derivatives and products obtained from this process. The present invention is characterized by the preparation of formulations of semicarbazonas and / or tiossemicarbazonas with cyclodextrins and their derivatives and products obtained from this process.The present invention is characterized by obtaining compounds of inclusion of semicarbazonas and / or tiossemicarbazonas in cyclodextrins and their derivatives tested in experimental models of epilepsy, allowed the reduction of anticonvulsant dose of loomg / kg for 35mg / kg, which can sign Ificar increase in bioavailability of compounds in biological systems.These results obtained in animal models, put semicarbazonas and / or tiossemicarbazonas included in cyclodextrins and their derivatives as candidates for new anticonvulsant agents. The present invention is characterized by increasing the effectiveness of the semicarbazonas and / or tiossemicarbazonas included in cyclodextrins and their derivatives, when compared to the free components.
机译:用环糊精及其衍生物和产物制得的半卡巴那霉素和/或硫代半卡巴那唑制剂的制备方法。本发明的特征在于制备具有环糊精及其衍生物和产物的氨基脲和/或硫代半碳氮烷的制剂和本发明的特征。在癫痫实验模型中测试的衍生物可降低loomg / kg的抗惊厥剂量(35mg / kg),这可以表明Ificar在生物系统中化合物的生物利用度增加。在动物模型中获得的这些结果将氨基脲和//环糊精及其衍生物中所含的替莫半碳氮烷或替半碳咔唑作为新的抗惊厥药的候选药物。当与游离组分相比时,本发明的特征在于增加了包括在环糊精及其衍生物中的半咔唑酮和/或噻吩半咔唑酮的有效性。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号